FdaApplication
NDA 213422
Identifiers
- fda_app_no: NDA213422
Properties
| Property | Value |
|---|---|
| applicant_name | MC2 THERAPEUTICS LTD |
| application_type | NDA |
| approval_date | 2020-07-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WYNZORA | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | 0.064%;0.005% | CREAM;TOPICAL |
1 product